The 4th European Course of in vivo Preclinical Assays in Cancer Therapy is an extensive training program designed to educate and update the biomedical research community on current trends and technological advances in in vivo preclinical assays in cancer. This course focuses mainly on use of tumour xenograft in mice and genetic engineered mouse models in anticancer drug testing context, including also antitumor immune response study, pharmacology and ethics. Experience of industrial pharmaceutical research will complete this session. Poster sessions are organised for the exchange of information and a means to improve share experiments. The course will be open to European PhD, post-docs and confirmed researchers from private and academic research. Lectures will be held in English. Deadline for registration: 15 April 2011. The number of participants will be restricted to 80 to promote exchange between participants and speakers. Registration will be done on the basis of 1st come-1st served. Location: The course will be held in Paris at the Curie Institut (Amphi Burg, 12 rue Lhomond, Paris, F-75005). Organisers: Virginie DANGLES-MARIE, Elisabetta MARANGONI and Sergio ROMAN-ROMAN Scientific committee: The members of the Scientific Committee presided by Marie-France are involved in the course as speakers or chairmen and will animate the exchanges between participants. Registration fees: Include course material, lunches, coffee breaks and social dinner. Academic: 300 euros (VAT included) Industry: 450 euros (VAT included) For information: preclinics2011@curie.fr